NO20033073D0 - Farmasöytisk sammensetning inneholdende citalopram - Google Patents

Farmasöytisk sammensetning inneholdende citalopram

Info

Publication number
NO20033073D0
NO20033073D0 NO20033073A NO20033073A NO20033073D0 NO 20033073 D0 NO20033073 D0 NO 20033073D0 NO 20033073 A NO20033073 A NO 20033073A NO 20033073 A NO20033073 A NO 20033073A NO 20033073 D0 NO20033073 D0 NO 20033073D0
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
composition containing
containing citalopram
citalopram
pharmaceutical
Prior art date
Application number
NO20033073A
Other languages
English (en)
Norwegian (no)
Other versions
NO20033073L (no
Inventor
Ken Liljegren
Per Holm
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20033073L publication Critical patent/NO20033073L/no
Publication of NO20033073D0 publication Critical patent/NO20033073D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20033073A 2001-01-05 2003-07-04 Farmasöytisk sammensetning inneholdende citalopram NO20033073D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100016 2001-01-05
PCT/DK2002/000003 WO2002053133A1 (en) 2001-01-05 2002-01-03 Pharmaceutical composition containing citalopram

Publications (2)

Publication Number Publication Date
NO20033073L NO20033073L (no) 2003-07-04
NO20033073D0 true NO20033073D0 (no) 2003-07-04

Family

ID=8159961

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033073A NO20033073D0 (no) 2001-01-05 2003-07-04 Farmasöytisk sammensetning inneholdende citalopram

Country Status (22)

Country Link
US (1) US20040058989A1 (ru)
EP (1) EP1351667A1 (ru)
JP (1) JP2004517111A (ru)
KR (1) KR20030070088A (ru)
CN (1) CN1484523A (ru)
AU (1) AU2001100195B4 (ru)
BG (1) BG108034A (ru)
BR (1) BR0206272A (ru)
CA (1) CA2358356A1 (ru)
CZ (1) CZ20032119A3 (ru)
EA (1) EA005596B1 (ru)
HR (1) HRP20030546A2 (ru)
HU (1) HUP0302531A3 (ru)
IL (1) IL156547A0 (ru)
IS (1) IS6857A (ru)
MX (1) MXPA03005965A (ru)
NO (1) NO20033073D0 (ru)
PL (1) PL362358A1 (ru)
SK (1) SK9912003A3 (ru)
WO (1) WO2002053133A1 (ru)
YU (1) YU54503A (ru)
ZA (1) ZA200304860B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406592C (en) * 2002-10-04 2003-09-30 Duchesnay Inc. Method of preparing pharmaceutical dosage forms containing multiple active ingredients
JP2006520390A (ja) * 2003-03-14 2006-09-07 ムルイェ、ニルマル 徐放性錠剤の製造方法
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006123243A2 (en) * 2005-05-20 2006-11-23 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram

Also Published As

Publication number Publication date
SK9912003A3 (en) 2003-12-02
PL362358A1 (en) 2004-10-18
KR20030070088A (ko) 2003-08-27
EA200300768A1 (ru) 2003-10-30
AU2001100195A4 (en) 2001-08-16
BR0206272A (pt) 2003-12-30
EA005596B1 (ru) 2005-04-28
JP2004517111A (ja) 2004-06-10
US20040058989A1 (en) 2004-03-25
ZA200304860B (en) 2004-06-30
CA2358356A1 (en) 2002-01-20
AU2001100195B4 (en) 2001-12-20
HUP0302531A3 (en) 2007-06-28
NO20033073L (no) 2003-07-04
EP1351667A1 (en) 2003-10-15
HRP20030546A2 (en) 2005-06-30
HUP0302531A2 (hu) 2003-11-28
YU54503A (sh) 2006-05-25
IS6857A (is) 2003-06-23
WO2002053133A1 (en) 2002-07-11
BG108034A (bg) 2005-02-28
MXPA03005965A (es) 2003-09-05
CN1484523A (zh) 2004-03-24
IL156547A0 (en) 2004-01-04
CZ20032119A3 (en) 2004-03-17

Similar Documents

Publication Publication Date Title
FI20011478A (fi) Farmaseuttinen koostumus
DK1524266T3 (da) Farmaceutisk sammensætning
NO20025450L (no) Ny farmasöytisk sammensetning
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
ITMI20010748A0 (it) Composizioni farmaceutiche
DK1395242T3 (da) Flydende farmaceutisk sammensætning
IS6915A (is) Lyfjablanda
EE05020B1 (et) Glburiidi ravimkoostis
BR0210619A (pt) composição
EE200300589A (et) Ravimkoostised
IS7081A (is) Lyfjablanda
NO20026123L (no) Farmasöytiske sammensetninger
FI20022128A0 (fi) Farmaseuttinen koostumus
DK1425005T3 (da) Farmaceutisk sammensætning indeholdende lumiracoxib
ITMI20011637A0 (it) Composizione farmaceutica contenente citalopram
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20031095L (no) Farmasoytiske sammensetninger
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
NO20033073L (no) Farmasöytisk sammensetning inneholdende citalopram
DE10291905D2 (de) Pharmazeutische Zusammensetzung
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
ITTO20020747A0 (it) Composizione
DE10107261B4 (de) Pharmazeutische Zusammensetzung
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application